Capital Finance
Enthusiasm for gene therapy remains high this week at the annual J.P. Morgan Healthcare Conference, despite uneven clinical trials and uncertainty over pricing, according to published reports.
Investors are gathering in San Francisco this week for the annual J.P. Morgan healthcare conference, the sector's biggest financial event and one where many biotech deals are expected to be announced.
Standard & Poor's has warned Anthem, Cigna, Aetna and Humana that the substantial debt needed to finance the proposed mergers between them may cause their credit ratings to fall.
While many healthcare stocks had a banner year in 2015, political pressure on drug prices is keeping some major pharmaceutical and biotech companies from hitting their full market potential, according to a recent analysis by Morningstar.
Well-known healthcare investment firm OrbiMed has closed a major new venture capital fund, OrbiMed Private Investments VI, with $950 million in limited partner commitments, the company announced in a statement.
The hospital-acquired infections prevention market in the United States is expected to grow 7 percent annually until 2020, according to a new report by by research-based management consulting firm Pharmaion, driven by increases in infections and chronic diseases among the aging population.
Perched on an exam table at the doctor's office watching the clinician type details about their medical problems into their file, what patient hasn't wondered exactly what the doctor is writing? As many as 50 million patients may have a chance to find out in the next few years, following the announcement this week of $10 million in new grants to expand the OpenNotes project, which works with medical providers to expand patient access to clinician notes.
When it comes to digital health funding, 2015 matched the record-breaking numbers of 2014 with more than $4.3 billion flowing into the industry, according to a Year in Review Report from Rock Health, a venture fund dedicated to backing digital health initiatives.
Kaiser Permanente Ventures is betting big on telemedicine, investing $10 million in Vidyo, a visual communications company that integrates high definition video communications into electronic health record systems and workflow, Vidyo announced Monday.
St. Louis-based Ascension Health has tapped Accretive Health as its sole revenue cycle system provider, the nonprofit Catholic health system announced this week, under a new 10-year contract extension that includes the total revamp of its revenue cycle system.